Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
27.21
-0.43 (-1.56%)
At close: Dec 5, 2025, 4:00 PM EST
27.46
+0.25 (0.92%)
After-hours: Dec 5, 2025, 7:54 PM EST
Olema Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 18.61 | 17.74 | 18.82 | 24.71 | 20.39 | 7.82 | |
| Research & Development | 141.78 | 124.52 | 86.14 | 82.27 | 51.1 | 13.7 | |
| Operating Expenses | 160.38 | 142.26 | 104.96 | 106.99 | 71.49 | 21.53 | |
| Operating Income | -160.38 | -142.26 | -104.96 | -106.99 | -71.49 | -21.53 | |
| Interest Expense | - | - | - | - | - | -0.65 | |
| Interest & Investment Income | 15.51 | 12.68 | 8.33 | 2.23 | 0.44 | 0.06 | |
| Other Non Operating Income (Expenses) | -0.08 | 0.1 | -0.02 | -0.03 | -0.05 | - | |
| Pretax Income | -149.96 | -129.47 | -96.66 | -104.79 | -71.1 | -22.12 | |
| Net Income | -149.96 | -129.47 | -96.66 | -104.79 | -71.1 | -22.12 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 1.87 | |
| Net Income to Common | -149.96 | -129.47 | -96.66 | -104.79 | -71.1 | -23.99 | |
| Shares Outstanding (Basic) | 83 | 59 | 45 | 40 | 40 | 7 | |
| Shares Outstanding (Diluted) | 83 | 59 | 45 | 40 | 40 | 7 | |
| Shares Change (YoY) | 54.75% | 29.83% | 13.13% | 1.19% | 462.91% | 170.75% | |
| EPS (Basic) | -1.81 | -2.20 | -2.14 | -2.62 | -1.80 | -3.42 | |
| EPS (Diluted) | -1.81 | -2.20 | -2.14 | -2.62 | -1.80 | -3.42 | |
| Free Cash Flow | -134.67 | -104.51 | -83.73 | -82.43 | -52.27 | -19.92 | |
| Free Cash Flow Per Share | -1.62 | -1.78 | -1.85 | -2.06 | -1.32 | -2.84 | |
| EBITDA | -159.96 | -141.87 | -104.58 | -106.63 | -71.33 | -21.52 | |
| D&A For EBITDA | 0.42 | 0.39 | 0.38 | 0.36 | 0.16 | 0.01 | |
| EBIT | -160.38 | -142.26 | -104.96 | -106.99 | -71.49 | -21.53 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.